Zihong Chen — SPARQNOW

At-a-Glance

Scientist at EvolveImmune Therapeutics
Holds a Ph.D. in biochemistry from Princeton University
Specializes in preclinical immuno-oncology and T cell biology
Possesses deep expertise in LC-MS metabolomics and CRISPR-based genetic screens
Skilled in designing and executing in vivo studies for drug efficacy and mechanistic insights

Biography

Zihong Chen is a Ph.D. biochemist currently serving as a Scientist at EvolveImmune Therapeutics. They hold a Ph.D. from Princeton University and bring over six years of preclinical immuno-oncology experience to their role.

Chen specializes in multi-omics and T cell biology, with deep expertise in LC-MS metabolomics. Their technical proficiencies include CRISPR-based genetic screens, molecular and cellular biology, and various bioanalytical techniques such as flow cytometry and ELISA.